Skip to main content

Improved Outcomes in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients Treated with Brincidofovir (CMX001, BCV) for Disseminated Adenovirus (AdV) Disease Compared to Literature: Updated Preliminary Results from the AdVise (CMX001-304) Study

Publication ,  Conference
Grimley, M; Papanicolaou, G; Maron, G; Chittick, G; Brundage, T; Bae, A; Mommeja-Marin, H; Nichols, WG; Prasad, VK
Published in: BONE MARROW TRANSPLANTATION
March 1, 2015

Duke Scholars

Published In

BONE MARROW TRANSPLANTATION

EISSN

1476-5365

ISSN

0268-3369

Publication Date

March 1, 2015

Volume

50

Start / End Page

S29 / S30

Location

Istanbul, TURKEY

Publisher

NATURE PUBLISHING GROUP

Conference Name

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grimley, M., Papanicolaou, G., Maron, G., Chittick, G., Brundage, T., Bae, A., … Prasad, V. K. (2015). Improved Outcomes in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients Treated with Brincidofovir (CMX001, BCV) for Disseminated Adenovirus (AdV) Disease Compared to Literature: Updated Preliminary Results from the AdVise (CMX001-304) Study. In BONE MARROW TRANSPLANTATION (Vol. 50, pp. S29–S30). Istanbul, TURKEY: NATURE PUBLISHING GROUP.
Grimley, M., G. Papanicolaou, G. Maron, G. Chittick, T. Brundage, A. Bae, H. Mommeja-Marin, W. G. Nichols, and V. K. Prasad. “Improved Outcomes in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients Treated with Brincidofovir (CMX001, BCV) for Disseminated Adenovirus (AdV) Disease Compared to Literature: Updated Preliminary Results from the AdVise (CMX001-304) Study.” In BONE MARROW TRANSPLANTATION, 50:S29–30. NATURE PUBLISHING GROUP, 2015.
Grimley M, Papanicolaou G, Maron G, Chittick G, Brundage T, Bae A, Mommeja-Marin H, Nichols WG, Prasad VK. Improved Outcomes in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients Treated with Brincidofovir (CMX001, BCV) for Disseminated Adenovirus (AdV) Disease Compared to Literature: Updated Preliminary Results from the AdVise (CMX001-304) Study. BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2015. p. S29–S30.

Published In

BONE MARROW TRANSPLANTATION

EISSN

1476-5365

ISSN

0268-3369

Publication Date

March 1, 2015

Volume

50

Start / End Page

S29 / S30

Location

Istanbul, TURKEY

Publisher

NATURE PUBLISHING GROUP

Conference Name

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences